Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  by Mizuno, Shinya et al.
Kidney International, Vol. 59 (2001), pp. 1304–1314
Hepatocyte growth factor suppresses interstitial fibrosis in a
mouse model of obstructive nephropathy
SHINYA MIZUNO, KUNIO MATSUMOTO, and TOSHIKAZU NAKAMURA
Division of Biochemistry, Department of Oncology, Biomedical Research Center, Osaka University
Graduate School of Medicine, Yamadaoka, Japan
Hepatocyte growth factor suppresses interstitial fibrosis in a animal models, focusing on glomerular injury [3, 4]. In
mouse model of obstructive nephropathy. addition to glomerulosclerosis, the molecular basis of
Background. As tubulointerstitial fibrosis (TIF) reflects the TIF has to be clarified as the severity of chronic tubuloin-prognosis of patients with various chronic renal diseases, the
terstitial injury correlates best with impaired renal func-pathogenesis of TIF has to be clarified. Transforming growth
tion and most accurately predicts renal dysfunction infactor-b (TGF-b) is a key mediator for renal fibrosis. We re-
ported that hepatocyte growth factor (HGF) prevents renal patients with CRF [5, 6]. It is important to address molec-
fibrosis in nephrotic mice. However, the function of HGF in ular mechanisms whereby interstitial fibrosis occurs and
chronic renal failure, except for nephrotic syndrome, remains progresses in chronically injured renal tissues in orderto be determined.
to minimize CRF-related pathological states [7, 8].Methods. Using mice subjected to unilateral ureter-ligated
Hepatocyte growth factor (HGF) was originally iden-obstruction (UUO), we investigated the roles of HGF in TIF,
as induced by obstructive nephropathy. Pathophysiological tified and cloned as a potent mitogen for mature hepato-
changes in the kidney after UUO treatment were analyzed cytes [9, 10]. It is now widely accepted that HGF is a
focusing on expressions of renal HGF and TGF-b, TIF, tubular regenerative as well as a cytoprotective molecule in sev-proliferation, and apoptosis. Neutralizing antibody against ro-
eral organs with various injuries [11–13]. HGF is mainlydent HGF, or recombinant human HGF (rhHGF), was admin-
produced in interstitial cells and targets epithelial andistrated to the UUO mice, and pathophysiological changes
after neutralization or supplements of HGF were analyzed. endothelial cells, thereby contributing to organogenesis
Results. In this UUO model, TIF with tubular apoptosis and tissue repair through mitogenic, motogenic, and
became evident, and it was accompanied by a decrease in renal morphogenic activities [11–13]. In renal development,HGF expression and an increase in renal TGF-b expression.
HGF is involved in morphogenesis and in the mesenchy-Neutralization of endogenous HGF accelerated the progres-
mal-epithelial transition during nephrogenesis [13, 14].sion of TIF, accompanied by increases in TGF-b expression
and tubular apoptosis as well as by decreases in tubular prolifer- In adult kidney, HGF derives largely from nonparenchy-
ation. In contrast, rhHGF attenuated TIF progression, and mal cells (that is, interstitial fibroblasts, macrophages,
there were decreases in TGF-b expression and tubular apopto- and endothelial cells) in remnant intact areas around thesis, and an increase in tubular proliferation.
injured parenchyme [15, 16]. Of importance, exogenousConclusions. Endogenous as well as exogenous HGF atten-
uated the progression of the fibrosis caused by obstructive HGF prevents tubular destruction and accelerates recov-
nephropathy in these mice. Thus, local reduction in HGF levels ery from renal dysfunction in cases of acute renal failure
may account for TIF in chronic renal diseases. [16–19]. Thus, HGF may play a role as a cytoprotective
and renotropic factor [15, 16, 20].
Recently, we found that endogenous as well as exoge-
Renal fibrosis, as evidenced by glomerulosclerosis and nous HGF prevents renal fibrosis in a mouse model of
tubulointerstitial fibrosis (TIF), is a histologic hallmark nephrotic syndrome [21–23]. On the other hand, Taka-
of chronic renal failure (CRF) [1, 2]. The molecular basis yama et al reported that transgenic mice, overexpressing
of renal fibrosis has been studied using experimental HGF at an extremely high level (that is, nonphysiological
level) from an early embryonic stage manifested CRF
(as characterized by glomerulosclerosis and tubular cystKey words: chronic renal disease, macrophages, renal fibrosis, trans-
forming growth factor-b, tubulointerstitial fibrosis. formation) [24]. Although HGF was clearly present in
renal biopsy specimens from CRF patients (includingReceived for publication May 3, 2000
primary glomerulonephritis and drug-induced nephritis)and in revised form September 25, 2000
Accepted for publication October 30, 2000 [25, 26], little is known about the role of HGF in CRF,
except in cases of spontaneous or transgenic CRF miceÓ 2001 by the International Society of Nephrology
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[21–24]. This background led us to determine whether after obstructive treatment, the UUO mice were given
rhHGF (1 mg/kg/day, every 12 hours, subcutaneously)HGF may play a therapeutic or pathogenic role during
the progression of other types of CRF. for four consecutive days then killed five days after the
induction of obstructive nephropathy.Obstructive nephropathy occurs as a result of urinary
congestion, which is caused by intraluminal or extralumi-
Immunohistochemical stainingsnal compressions (such as congenital hypoplasia, urinary
calculi, prostate tumor, and pregnancy) [27]. Rodents Renal tissues were fixed in cold 70% ethanol for 12
hours and embedded in paraffin in a routine fashion.subjected to unilateral ureter-ligation obstruction (UUO)
have been widely used as a model to investigate the Tissue sections were cut at a thickness of 4 mm and were
dewaxed and stained with hematoxylin and eosin. Topathogenesis of TIF [28–30]; however, potential involve-
ment of HGF in TIF has yet to be determined in this identify tubular growth, ethanol-fixed sections were
stained with peroxidase-conjugated anti-human prolifer-model of fibrosis. We now provide evidence that HGF
may play a role in suppressing TIF, whereas a decrease ating cellular nuclear antigen (PCNA) monoclonal anti-
body (EPOS System; Dako, Glostrup, Denmark) [21].in renal HGF level may facilitate the progression of TIF.
To detect apoptotic cells, an in situ end-labeling method
was applied on dewaxed sections using a kit (TACM
METHODS
TdT system; Trevigen Inc., Gaithersburg, MD, USA)
Animal treatments [21]. To evaluate infiltration of interstitial macrophages,
anti-mouse Mac-1 rat monoclonal antibody (1:400; Chemi-Six-week-old female ICR (22 to 24 g body wt; Slc
Japan, Hamamatsu, Japan) were anesthetized with keta- con, Temecula, CA, USA) was applied to the dewaxed
sections as the primary reaction, followed by a secondmine chloride (80 mg/kg, subcutaneously) and xyladine
sulfate (8 mg/kg, subcutaneously). Under general anes- reaction with biotin-labeled anti-rat IgG goat IgG (Vector,
Burlingame, CA, USA). Finally, an avidin-biotin couplingthesia, they underwent left proximal ureteral ligation, as
described elsewhere [28–30]. All experimental proce- (ABC) reaction was performed on the sections, using a
kit (Vectstain Elite; Vector). To identify myofibroblasts,dures were carried out with great care according to
guidelines for animal welfare set up by Osaka University monoclonal IgG against human a-smooth muscle actin
(a-SMA; EPOS System; Dako) was used [21, 22]. ToGraduate School of Medicine.
To analyze the histologic and biochemical changes examine the extent of interstitial fibrosis, rabbit IgG
against rat type I collagen (1:200; CosmoBio, Tokyo,during progression of TIF, 24 mice were killed at 0, 1.5,
3, and 7 days after the UUO treatment. At the time of Japan) was used for the primary reactions, followed by
the ABC technique. To visualize the expressions of growthnecropsy on six mice, renal tissues were fixed in cold
70% ethanol for histologic examinations, as described factors, rabbit IgG against porcine and human trans-
forming growth factor-b1 (TGF-b1), -2, -5 (pan-TGF-b;later in this article. The remaining tissues were immedi-
ately frozen in liquid nitrogen and stocked at 2808C for 1:100; R&D Laboratory, Minneapolis, MN, USA), and
rabbit IgG against rat HGF (1:1000; Institute of Immu-biochemical analyses, as discussed later in this article.
For neutralization of endogenous HGF, an anti-HGF nology, Tokyo, Japan) were used for the primary reac-
tions, and the ABC technique was applied using theantibody was raised by immunizing rat HGF in healthy
rabbits, and the IgG fraction was purified using Protein Vectastain kit [21, 22].
A-Sepharose (Pharmacia, Uppsala, Sweden). This anti-
Semiquantitation of renal phenotypes withrat HGF antibody shows cross-reactivity with mouse
histologic scoresHGF (but not with human HGF) and modulates tissue
phenotypes in the CRF kidney [21], pancreatic islets Tubular lesions, characterized by tubular dilation and
epithelial desquamation with interstitial expansions, were[31], and lung [32] in rodents subjected to parenchymal
injuries. The UUO mice were randomly divided into two graded according to the extent of cortical involvement
on a scale from 0 to 4: 0 5 normal; 1 5 involvement ofgroups and injected with rabbit anti-rat HGF IgG (N 5
8) or normal rabbit IgG (N 5 8, 250 mg/day/mouse, less than 25% of the cortex; 2 5 involvement up to 25
to 50% of the cortex; 3 5 involvement up to 50 to 75%intraperitoneally) for the initial three days. These mice
were killed three days after the UUO treatment. of the cortex; 4 5 extensive damage involving more than
75% of the cortex. Then they were expressed as tubularTo evaluate the effect of exogenous HGF on the pro-
gression of TIF in UUO mice, 12 UUO mice were gener- injury scores [21, 22]. To evaluate the degree of tubular
growth and apoptosis, tubular PCNA and TUNEL indi-ated and injected with recombinant human HGF (rhHGF).
rhHGF was purified from conditioned medium of Chi- ces were, respectively, determined by counting numbers
of positive tubular cells in at least 20 randomly chosennese hamster ovary cells transfected with expression vec-
tor containing HGF cDNA of the five amino acids- nonoverlapping fields [3400 high-power field (hpf)]. The
degree of macrophage infiltration was expressed as thedeleted type, as described [16, 17, 19, 21, 22]. One day
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Fig. 1. Natural course of tubular changes in unilateral ureter-ligated obstruction (UUO) mice after the onset of obstructive nephropathy. (A)
Change in tubular injury score, and representative photomicrographs of tubular lesions after UUO manipulation (H.E. stain, 3130). (B) Change
in tubular proliferating cellular nuclear antigen (PCNA) score, and representative photographs of epithelial cell proliferation in proximal tubules
(PCNA stain, 3240). (C) Apoptotic changes in tubules during the progression of obstructive nephropathy (TdT stain, 3240). The overall mean 6
SD histological scores were calculated based on individual values (N 5 6), which were determined from at least 20 high-power fields (hpf) per mouse.
Mac-1 score, determined by counting numbers of mono- man HGF as the antibody reacts with mouse or rat but
not human HGF [21]. Renal TGF-b1 levels were deter-nuclear cells immunoreactive for Mac-1, in at least 20
randomly chosen hpf. Immunoreactive signals for inter- mined in an ELISA system using a commercial kit
(Quantikine TGF-b1; R&D) [21, 22]. Furthermore, typestitial a-SMA and for col (1) were observed in at least
20 randomly chosen hpf and scored on the scale of 0 5 I and type III collagen levels were measured by a dye-
binding method using a kit (Sircol collagen assay; Bio-absent; 1 5 mild; 2 5 moderate; and 3 5 severe [21, 28].
To quantitate the renal expression of TGF-b or HGF, color Ltd., Belfast, Ireland) [21].
sections of UUO kidney were examined under a light
Statistical analysesmicroscopy, and the degree of renal expression was
shown as a mean value of the following histochemical All data were expressed as mean 6 SD. An unpaired
two-tailed t-test was used to compare the means, and ascales: 0 5 no staining; 0.5 5 trace staining; 1 5 light
staining; 2 5 moderate staining; and 3 5 intense staining value of P , 0.05 was considered to have statistical
significance.in at least 20 randomly chosen hpf [33]. These semiquan-
titative analyses were all made in a blinded fashion.
RESULTSBiochemical analysis of renal tissues
Changes in the kidney after UUO treatmentRenal tissue extract was prepared as described pre-
viously [21]. HGF levels were determined in enzyme- Tubular dilation with epithelial atrophy and/or de-
squamation occurred three days after UUO, and tubulo-linked immunosorbent assays (ELISAs) using a commer-
cial kit (HGF EIA; Institute of Immunology). In HGF interstitial lesions (including the interstitial expansion
and mononuclear cell infiltration) were predominant inELISA, mouse or rat HGF is distinguishable from hu-
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Fig. 2. Changes in interstitial events in UUO mice subjected to obstructive nephropathy. (A) Changes in macrophage infiltration. The distribution
of Mac-1-positive macrophages in the interstitial regions and a semiquantitative Mac-1 score are shown (Mac-1 stain, 3240). (B) Changes in
interstitial myofibroblast formation [a-smooth muscle actin (a-SMA) stain, 3160]. (C) Fibrotic changes in tubulointerstitial regions, as estimated
by type I collagen [Col (1)] accumulation [Col (1) stain, 3220]. Histological scores are expressed as mean 6 SD (N 5 6).
the kidney on day 7 after UUO (Fig. 1A). Consistently, Expression of TGF-b and HGF in the UUO kidney
the tubular injury score increased for up to seven days Transforming growth factor-b may play an important
after UUO (day 3, 1.17 6 0.39; day 7, 2.68 6 0.20). In role in the onset and progression of tubular atrophy and
an early stage of the obstructive nephropathy, tubular TIF in UUO models [28, 29]. Interstitial cells positive
growth became evident, and the PCNA score showed a for TGF-b were rare for up to three days after UUO,
whereas numerous TGF-b–positive cells were noted inpeak at three days after UUO (17.5 6 4.32 tubular cells/
the interstitial areas of the kidney seven days after UUOhpf; Fig. 1B). In contrast to the tubular growth, tubular
(Fig. 3A). To identify TGF-b–positive cells, immuno-cells positive for TdT (that is, an apoptotic marker) in-
staining of serial sections with an anti–Mac-1 antibody (acreased, especially seven days after UUO (5.64 6 1.85
marker for macrophages) was done. Most TGF-b–express-tubular cells/hpf), which suggested a rapid progression
ing cells were immunoreactive for the marker antibodyto tubular cell death (Fig. 1C).
(Fig. 3A, insert), thus indicating that macrophages are aIn parallel to the tubular apoptosis, macrophages
major source of TGF-b. Additionally, TGF-b–immuno-(identified as Mac1-positive cells) became evident, par-
positive signals were also seen in spindle-shaped fibro-ticularly around the atrophied tubules (day 1.5, 2.38 6
blastic cells as well as in tubular epithelial cells, as de-
0.56 cells/hpf; day 7, 8.63 6 1.68 cells/hpf; Fig. 2A). Inter- scribed elsewhere [28, 29]. The TGF-b staining score
stitial areas stained with anti–a-SMA antibody rapidly increased, especially seven days after UUO (day 1.5,
expanded from three days after the onset of UUO, thus 0.59 6 0.24; day 7, 3.84 6 1.18; Fig. 3C, left). On the
indicating myofibroblast hyperplasia (Fig. 2B). Conse- other hand, HGF was detected in peritubular cells (and
quently, interstitial fibrosis, as evidenced by type I colla- partially on tubular cells) from three days following
gen overexpression, rapidly progressed from three days UUO (Fig. 3B). The HGF score reached a peak at three
after UUO (type I collagen score on day 7, 2.25 6 0.15; days and decreased at seven days after UUO (Fig. 3C,
right).Fig. 2C).
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Fig. 3. Differential expression of TGF-b and HGF in the obstructed kidney of UUO mice. (A) Immunohistochemical findings of renal TGF-b
expression after ureteral ligation (3240). The insert represents a positive signal for the Mac-1 antigen (a marker for macrophages), immunostained
on a serial section (3320). (B) Immunostaining for HGF expression in tubulointerstitium in the UUO kidney (3240). (C) Changes in renal
expression of TGF-b and HGF as estimated from the immunohistochemical scores. (D) Alterations in HGF, TGF-b1 and types I and III collagen
levels as determined by ELISA in the UUO kidneys. Immunohistochemical scores and biochemical values are expressed as mean 6 SD (N 5 6).
We quantitated HGF and TGF-b1 protein levels in 0.59 ng/g · tissue). As a result, the types I and III collagen
levels showed a parallel increase in TGF-b1 levels.the UUO kidneys using an ELISA method (Fig. 3D).
Renal HGF levels rapidly increased, reaching a peak on
Advanced fibrosis by neutralization of endogenous HGFday 3 after UUO (322.3 6 28.9 ng/g · tissue). However,
seven days following UUO, HGF levels declined to half To determine the role of intrinsic HGF in UUO mice,
we examined renal phenotypes after anti-HGF IgG treat-of those seen three days after UUO. In contrast, renal
TGF-b1 levels gradually increased for up to seven days ment. PCNA-positive tubular cells were significantly re-
duced in number in the anti-HGF IgG-treated mice asafter UUO (day 3, 1.34 6 0.45 ng/g · tissue; day 7, 2.38 6
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Fig. 4. Aggravating effects of anti-HGF anti-
body (a-HGF IgG) treatment on renal pheno-
types in UUO mice. (A) Suppressive effect of
anti-HGF IgG treatment on tubular prolifera-
tion (PCNA stain, 3260). (B) Aggravation of
tubular apoptotic changes by anti-HGF IgG
treatment (TdT stain, 3260). (C) Accelera-
tion of interstitial fibrosis by HGF-neutraliza-
tion [collagen (1) stain, 3130]. Data are ex-
pressed as mean 6 SD (N 5 8); *P , 0.05,
**P , 0.01, and ***P , 0.001 vs. the normal
IgG group (control).
Table 1. Effect of normal IgG or anti-HGF IgG on renal phenotypescompared with findings in normal IgG-injected mice
in UUO mice(8.79 6 2.27 vs. 17.2 6 4.07 cells/hpf, P , 0.01; Fig. 4A).
Normal Anti-HGFConversely, HGF-neutralized mice showed a higher TdT
Parameters IgG IgG P valuescore compared with findings in mice given a placebo
TGF-b1 level ng/mL 1.260.4 2.060.5 ,0.05(2.81 6 1.03 vs. 1.13 6 0.42, P , 0.001; Fig. 4B). The
HGF level ng/mL 217.9624.3 161.3617.4 ,0.01renal TGF-b1 level was significantly higher in the HGF- TI score 1.8160.27 2.3860.31 ,0.05
neutralized mice than in mice given a placebo, while Mac-1 score 3.2160.58 4.4261.05 NS
a-SMA score 1.0260.29 1.3460.39 NSanti-HGF IgG treatment decreased renal HGF levels to
Collagen (1, 3) level mg/g 136.5648.3 193.9637.6 ,0.0574% over the control (Table 1). There was a definite trend
Data are mean 6 SD (N 5 8). Abbreviations are: HGF, hepatocyte growththat other fibrogenic parameters (including tubular injury,
factor; UUO, unilateral ureter-ligated obstruction; TGF-b, transforming growth
interstitial Mac-1 and a-SMA scores, and renal collagen factor-b; TI, tubular injury; a-SMA, a-smooth muscle actin.
levels) were also increased in UUO mice given anti-
HGF IgG (Table 1). Consequently, the HGF-neutralized
UUO mice manifested a rapid progression of TIF, as
ulate proliferation and apoptotic changes in tubular epi-evidenced by interstitial type I collagen score (Fig. 4C).
thelial cells. Tubular growth in the rhHGF-treated UUO
Growth and protection of tubules by exogenous HGF mice was sustained at an 1.4-fold higher level over that
in saline-injected UUO mice (Fig. 5A). On the otherTo determine the preventive role of HGF in obstruc-
tive nephropathy, we asked whether rhHGF would mod- hand, tubular apoptosis was significantly suppressed in
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Fig. 5. Beneficial effect of recombinant hu-
man HGF (rhHGF) supplementation on tubu-
lar events in UUO mice. (A) Enhancement of
tubular proliferation by rhHGF administra-
tion (PCNA stain, 3260). (B) Suppressive
effect of rhHGF supplement on tubular apop-
tosis (TdT stain, 3260). (C) Prevention of tu-
bular epithelial desquamation by rhHGF ther-
apy (H.E. stain, 3180). Histological scores are
expressed as mean 6 SD (N 5 6); *P , 0.05
and **P , 0.01 vs. the saline group (control).
the rhHGF-injected mice as compared with findings in was reduced to 39% of the control level (Fig. 6B). In
accordance with reduced TGF-b expression, the intersti-the control mice (TdT score, 2.49 6 0.78 vs. 4.01 6 1.15,
P , 0.05; Fig. 5B). Consistently, tubular destruction, tial a-SMA score was significantly lower in the rhHGF-
treated mice than in control mice (Fig. 6C). Consequently,evaluated as the tubular injury score, was significantly
suppressed by rhHGF (1.23 6 0.42 vs. 2.56 6 0.13, P , rhHGF attenuated the progression of renal fibrosis, as
evaluated by the type I collagen score (Fig. 6D).0.05; Fig. 5C). Overall, it was shown that not only endoge-
nous but also exogenous HGF have renotropic and anti- Attenuation of TIF by rhHGF led to the hypothesis
that a reciprocal balance between HGF and TGF-b1 mayapoptotic effects on tubular epithelial cells in this model
of obstructive nephropathy. occur in the progression of TIF in cases of obstructive
nephropathy. In biochemical evaluations using ELISA,
Suppression of TIF by rhHGF there was a strong trend for exogenous HGF (that is,
human HGF) to increase endogenous HGF (that is, mouseTo evaluate antifibrogenic functions of rhHGF, we
focused on interstitial changes in the UUO kidney. The HGF) levels (Fig. 7A). In contrast, the renal TGF-b1
level was reduced in the rhHGF group with a significantnumber of Mac-1–positive macrophages was significantly
lower in the rhHGF group than in the saline group (3.61 6 difference (P , 0.05; Fig. 7B). Furthermore, the renal
types I and III collagen levels in the UUO mice were0.73 vs. 6.85 6 1.05 cells/hpf, P , 0.01; Fig. 6A). Likewise,
rhHGF treatment led to a significant reduction in renal also reduced to a significant level when HGF was given
exogenously (Fig. 7C), and this was in agreement withTGF-b expression (including Mac-1–positive macro-
phages): The TGF-b score in the rhHGF-treated mice immunohistochemical evidence.
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Fig. 6. Suppression of injury and fibrogenic
events in tubulointerstitium of UUO kidney
by HGF therapy. (A) Suppressive effect of
rhHGF injection on macrophage infiltration
(Mac-1 stain, 3240). (B) Reduction of TGF-b
expression by rhHGF administration (TGF-b
stain, 3240). The insert represents a positive
signal for the Mac-1 antigen expressed on a
serial renal section (3320). (C) Suppression
of myofibroblast accumulation by rhHGF
therapy (a-SMA stain, 3130). (D) Attenuat-
ing effect of rhHGF supplement on progres-
sion of interstitial fibrosis [collagen (1) stain,
3130). Immunohistochemical scores are ex-
pressed as mean 6 SD (N 5 6); *P , 0.05
and **P , 0.01 vs. the saline group (control).
DISCUSSION pression of TGF-b and the onset of glomerular and inter-
stitial fibrosis [33–35]. Consistently, elevated expressionIn renal disease of diverse etiology, especially at an
of TGF-b was noted in animal models of renal fibrosis,end stage of CRF [1, 2], TIF is a reliable histologic hall-
including the UUO model [7, 8, 28, 29]. Importantly,mark. Thus, it is important to determine how TIF occurs
suppression of TGF-b production in an UUO rat modeland progresses at a molecular level. Distinct lines of
evidence suggest a causal relationship between overex- by antisense oligonucleotide retards the progression of
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syndrome [21], whereas a supplement of HGF decreased
the renal TGF-b level and resulted in prevention/recov-
ery from nephrosis-related CRF conditions [22]. Taken
together, we propose that the balance between TGF-b
and HGF may play a definite role in the regulation of
TIF in chronic renal diseases.
Given that a reciprocal balance between TGF-b and
HGF regulates pathology of TIF, how HGF attenuates
TIF and how this reciprocal balance occurs had to be
given attention. Previous studies indicated that TGF-b
and HGF are counteracting in their biological activities.
TGF-b strongly stimulates the synthesis of extracellular
matrix (ECM) proteins [37] and the production of inhibi-
tors of proteinases involved in ECM breakdown, includ-
ing plasminogen activator inhibitor-1 or tissue inhibitor
of metalloproteinases [33, 38, 39]. In contrast, HGF stim-
ulates or induces proteinases involved in breakdown of
ECM proteins, including membrane type 1 matrix metal-
loproteinase, urokinase-type plasminogen activator, and
Fig. 7. Changes in endogenous HGF, TGF-b1 and collagen levels in some matrix metalloproteinases in several types of cells
UUO mice by HGF supplement. (A) An increase in endogenous HGF [40–42]. TGF-b induces growth arrest [43] and apoptosislevel by rhHGF treatment. (B) Suppressive effects of rhHGF treatment
[44] in renal tubular cells and endothelial cells, whileon renal TGF-b1 levels. (C) Reduction of collagen (1, 3) level by rhHGF
treatment. Data are expressed as mean 6 SD (N 5 6); *P , 0.05 vs. HGF exhibits mitogenic [45, 46] and anti-apoptotic [47, 48]
the saline group (control). activities in these cell types. HGF induces branching
tubulogenesis in renal epithelial cells, but inhibition is
seen with TGF-b [49]. Thus, in addition to overexpres-
sion of TGF-b, a reduction in renal HGF levels mightTIF [36], thereby suggesting a pivotal role for TGF-b
in fibrogenic events after obstructive nephropathy. Our allow for an increased susceptibility to TIF, while HGF
neutralization could result in a rapid progression of TIF.present study also noted that expression of TGF-b in-
creased after UUO, and the increase in TGF-b expres- With regard to the reciprocal molecular balance, TGF-b
strongly inhibits gene expression of HGF in various typession correlated well with fibrotic changes of interstitial
regions in the kidney subjected to UUO. of cells [50–52], and this TGF-b1–induced suppression
of HGF expression seems to explain why the overexpres-During a rapid progression of TIF, expression of renal
HGF increased until three days after UUO, whereas it sion of TGF-b is associated with a decreased renal HGF
expression in a later stage after UUO. Since macro-decreased in an advanced stage of TIF. To determine
physiological functions of HGF, as related to UUO treat- phages are a major source of TGF-b in the UUO model
[53] and the infiltration of macrophages was less in HGF-ment, we used two distinct approaches: biological neu-
tralization of HGF by antibody administration and aug- treated mice than in saline-injected mice, a reduction in
TGF-b levels by HGF may be achieved, at least in part,mentation of HGF by supplement of exogenous HGF.
These two approaches clarified the potential role of HGF by suppression of macrophage infiltration. An alterna-
tive possibility is direct inhibition of TGF-b productionin progression of TIF. Neutralization of HGF increased
renal expression of TGF-b, accompanied by increases in by HGF [41], although as yet we have not obtained
evidence in renal cells to support this possibility.interstitial type I collagen. In contrast, supplement of
HGF attenuated renal expression of TGF-b, accompa- In the UUO model, we found that changes in HGF
expression coincide with changes in tubular prolifera-nied with a decrease in the interstitial collagen accumula-
tion. Therefore, HGF is likely to play a role to retard tion: Tubular proliferation increased at an early stage
of obstructive nephropathy, while it decreased in theor suppress the onset of TIF, and a decline of HGF,
which occurs in a reciprocal manner to a further increase advanced stage of TIF, in a reciprocal relationship to
the decrease in renal HGF level. These observationsin TGF-b expression in a later stage after UUO, may
allow for the rapid progression to TIF. We previously suggest an involvement of HGF as well as TGF-b in the
regulation of tubular proliferation and apoptosis duringreported an association of the reciprocal balance be-
tween TGF-b and HGF regarding the onset and preven- the progression of TIF. More clearly, the modification of
HGF achieved by its neutralization or supplementationtion of CRF using nephrotic ICGN mice [21–23]: The
TGF-b–dominant balance achieved by neutralization of strengthens the involvement of HGF and TGF-b in regu-
lating tubular proliferation and apoptosis. NeutralizationHGF accelerated the pathology of CRF after nephrotic
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